Search

everythinglearnresearchcommunity

for

Search:↓

The authors maintain there is a significant link between vitamin D deficiency and central centrifugal cicatricial alopecia in Black patients, and call for more research on the topic.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

Accurate diagnosis is crucial for effective treatment of hair loss.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Hair shaft malformation contributes to Central Centrifugal Cicatricial Alopecia.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

CCCA can affect both genders and all ages, and it has a genetic component.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Enlarged sweat gland ducts may indicate scarring hair loss.

Low ferritin levels are linked to chronic hair loss in women.

DNA analysis can help tailor alopecia treatment.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Adipose tissue and eccrine gland displacement are common in certain alopecias but don't help differentiate between them.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.

The conclusion is that an algorithm using trichoscopy helps diagnose different types of hair loss but may need updates and a biopsy if results are unclear.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.